FMFerenc Emil Mózes

Ferenc Emil Mózes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ferenc Emil Mózes has a total of 436 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Author Correction: Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study

    by Michael Pavlides, Yasaman Vali, Ferenc E. Mózes, Kristy Wonders, Salma Akhtar, Paul D. Hockings, Elizabeth Shumbayawonda, Kay Pepin, Isabel Fernandez-Lizaranzu, Diana Julie Leeming, et al.

  • Open Access

    Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study

    by Michael Pavlides, Yasaman Vali, Ferenc E. Mózes, Kristy Wonders, Salma Akhtar, Paul D. Hockings, Elizabeth Shumbayawonda, Kay Pepin, Isabel Fernandez-Lizaranzu, Diana Julie Leeming, et al.

    There is a need for robust evaluations of noninvasive biomarkers for metabolic dysfunction-associated steatotic liver disease. This prospective multicenter study assessed the diagnostic accuracy of imaging (including liver stiffness measurement (LSM) using magnetic resonance elastography (MRE) and FibroScan (vibration-controlled transient elastography (VCTE)), serum biomarkers (including NIS2+) and composite scores (including Agile 3+ and Agile 4) for centrally read steatohepatitis and fibrosis. For cirrhosis, several biomarkers exceeded the minimum acceptable performance criterion (MAC), including MRE (area under the receiver operating curve (AUC) 0.91; P < 0.01), VCTE-LSM (AUC 0.87; P < 0.01), Agile 3+ (AUC 0.89; P < 0.01) and Agile 4 (AUC 0.88; P < 0.01). Among 357 participants, fibrosis stages F0–F4 were present in 12%, 16%, 25%, 32% and 15%, respectively. NIS2+ had the highest diagnostic accuracy among serum biomarkers for metabolic dysfunction-associated steatohepatitis (MASH; AUC 0.83) and at-risk MASH (MASH with at least stage 2 fibrosis; AUC 0.82), although neither significantly exceeded the MAC ( P = 0.15 and P = 0.19). Among imaging biomarkers, MRE showed the highest performance for MASH (AUC 0.71) and at-risk MASH (AUC 0.75), but these remained below the MAC. For fibrosis staging, performance was stronger: MRE met the MAC for advanced fibrosis (AUC 0.91; P < 0.01), as did Agile 3+ (AUC 0.84; P = 0.03). For cirrhosis, several biomarkers exceeded the MAC, including MRE (AUC 0.91; P < 0.01), VCTE-LSM (AUC 0.87; P < 0.01), Agile 3+ (AUC 0.89; P < 0.01) and Agile 4 (AUC 0.88; P < 0.01). Serum biomarkers tended to outperform imaging for identifying at-risk MASH, whereas elastography and composite scores showed excellent accuracy for staging advanced fibrosis and cirrhosis.


  • Open Access

    Faster and More Robust CK Reaction Rate Estimation at 3T Using Acquisition‐Weighted 31 P Cardiac 1D ‐ MRSI With Compartment‐Based Reconstruction

    by Aaron Axford, Iveta Pajanová, William D. Watson, Andrew C. Tyler, Roshan Xavier, Ferenc E. Mózes, Oliver J. Rider, Damian J. Tyler, Ladislav Valkovič

    Purpose: Quantification of the creatine kinase (CK) forward reaction rate ( k f ) in the human heart using phosphorus magnetic resonance spectroscopy is clinically important; however, it is limited by long acquisition times, operator subjectivity in analysis, and potential skeletal muscle contamination. This study evaluates if combining compartment‐based reconstruction techniques with acquisition‐weighted (AW) Triple Repetition Time Saturation Transfer (TRiST) acquisitions could overcome these challenges. Methods: Healthy volunteers were scanned with a fully weighted (FW) TRiST protocol twice, and once with an AW TRiST protocol on a 3T MRI. The resulting spectra were reconstructed with conventional Fourier Transform (FT), as well as compartment‐based reconstruction techniques: Spectroscopy with Linear Algebra Modeling (SLAM), Spectral Localization by IMaging (SLIM), and an unweighted mean of the FT spectra (ROI‐FT). k f values were calculated and compared across reconstruction methods and acquisition types. Results: The cardiac k f values from FW TRiST were 0.21 ± 0.07 s −1 (FT), 0.26 ± 0.08 s −1 (SLAM), 0.26 ± 0.07 s −1 (SLIM), and 0.30 ± 0.10s −1 (ROI‐FT). Corresponding values from AW TRiST were 0.27 ± 0.07 s −1 , 0.25 ± 0.05 s −1 , 0.25 ± 0.04 s −1 , and 0.24 ± 0.08 s −1 , respectively. No significant differences were observed between FW and AW results. A significant decrease in cardiac PCr/ATP ratios was observed for SLAM and SLIM reconstructed data, suggesting decreased signal contamination from skeletal muscle. Conclusion: Compartment‐based reconstruction techniques minimize the operator subjectivity present in the current FT method of analyzing TRiST experiments, in addition to reducing skeletal muscle contamination. When combined with an AW acquisition, scan times were reduced by 47% without compromising k f accuracy. This method provides a more robust and efficient evaluation of in vivo cardiac metabolism.

  • Open Access

    Repeatability of Rapid Human Cardiac Phosphorus MRSI ( 31 P ‐ MRSI ) Using Concentric Ring Trajectory Readouts at 7 T

    by Ferenc E. Mózes, William T. Clarke, Andrew Tyler, Jabrane Karkouri, Fabian Niess, Jack J. J. J. Miller, Christopher T. Rodgers, Wolfgang Bogner, Ladislav Valkovič

    Purpose: PCr/ATP ratio is determined at 7 T typically using Fourier‐transform based magnetic resonance spectroscopic imaging sequences (FT‐MRSI). These sequences require acquisition times longer than desirable for inclusion in cardiac clinical trials. Concentric ring trajectory (CRT‐MRSI) has been described as an accelerated alternative k‐space sampling method. In this work we aim to establish the inter‐ and intra‐session repeatability of three different CRT protocols and compare their voxel‐based PCr/ATP ratios to compartment‐based PCr/ATP values extracted with spectroscopy using a linear algebraic model (SLAM) method. Methods: Seven healthy volunteers were scanned twice on two different days. Each time a 6.5‐min 3D FT‐MRSI acquisition with 10 × 10 × 10 resolution was followed by a 2.5‐min CRT‐MRSI with matched resolution, a 1.5‐min CRT‐MRSI with matched resolution, and a 6.9‐min CRT‐MRSI with 12 × 12 × 12 resolution. Spectra from a mid‐septal voxel and the cardiac compartment were fitted with the OXSA toolbox. PCr/ATP ratio was quantified for inter‐ and intra‐session repeatability analysis. Results: Paired repeated measurements were not significantly different within subjects. Good inter‐ and intra‐session agreement was observed between FT‐MRSI and each CRT‐MRSI protocol. CRT‐MRSI protocols all had larger coefficients of repeatability (CoR) than FT‐MRSI. CRT‐SLAM‐based PCr/ATP values had lower CoR than voxel‐based data except for 2.5‐min CRT‐SLAM, and high‐resolution CRT‐SLAM had lower inter‐session CoR compared to FT‐MRSI (1.42 vs. 2.21). Conclusion: We established the repeatability of CRT‐MRSI‐based PCr/ATP values and showed higher SNR and lower CoR for CRT‐SLAM. Our findings allow shorter 31 P MRS acquisition times and the use of more advanced energetics‐probing techniques in clinical studies.


  • Open Access

    Investigation of the Effect of Isotonic Drinks on Quantitative MRI Markers of the Liver and Spleen

    by Natassa N. Pittas, Michael Pavlides, Ferenc E. Mózes

    Quantitative MRI markers of the liver are attractive diagnostic tools of metabolic dysfunction‐associated steatotic liver disease (MASLD). However, measurements are confounded by physiological factors, such as hydration. The aim of this study is to evaluate the dynamic effects of hydration with isotonic drinks on quantitative MRI measurements of the liver in healthy male individuals. Shortened modified Look‐Locker inversion recovery‐based (shMOLLI) , , proton density fat fraction (PDFF), apparent diffusion coefficient (ADC), stiffness, and volume of the liver, as well as shMOLLI and volume of the spleen were measured repeatedly in six healthy male volunteers at 3 T after ingesting 0.5, 1.0, and 1.5 L of isotonic drink on three different days. data were fitted to a first‐order linear time‐invariant system model, descriptive statistics were calculated for the other parameters, and linear mixed models were employed to assess co‐variates of quantitative MRI parameters. Liver showed a maximum absolute increase of 58, 60, and 90 ms, while spleen showed a maximum absolute increase of 45, 70, and 150 ms corresponding to 0.5, 1.0, and 1.5 L of isotonic drink, respectively. The maximum change in ADC, , liver volume and spleen volume gradually increased, while that in liver stiffness gradually decreased with increasing amounts of isotonic drinks. PDFF values had no dependence on the volume of ingested isotonic drink. First‐order models showed increasing time constants for both the liver and the spleen corresponding to increasing isotonic drink volumes. Liver time constants were only dependent on ingested drink volume. This study explored the effect of different volumes of isotonic drink and quantitative liver MRI markers. We found that the increase in likely bears clinical significance, however, the variation observed in the other parameters need further investigation and validation in a larger cohort.

  • Open Access

    Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD

    by Ahmad Moolla, Toryn Poolman, Nantia Othonos, Jiawen Dong, Kieran Smith, Thomas Cornfield, Sarah White, David W. Ray, Sofia Mouchti, Ferenc E. Mózes, et al.


  • Open Access

    Accurate and precise in vivo liver 3D T 1 mapping at 3T

    by Gabriela Belsley, Ferenc E. Mózes, Damian J. Tyler, Matthew D. Robson, Elizabeth M. Tunnicliffe

    Purpose: To develop an accurate and precise liver 3D mapping method using only scanner‐agnostic sequences. Methods: While the spoiled gradient‐recalled echo sequence is widely available on clinical scanners, variable flip angle mapping methods based on this sequence provide biased estimates, with the largest systematic error arising from inhomogeneities. To correct for this, the flip angle was mapped using a 2D gradient‐echo double‐angle method approach. To correct for the confounding effect of fat on liver and , Dixon and fat saturation techniques were used in combination with the variable flip angle and the map acquisitions, respectively. The and mapping methods were validated with a ‐phantom against gold standard methods. An intra‐ and inter‐repeatability study was conducted at 3T in 10 healthy individuals' livers. Results: The developed 3D mapping method achieved an excellent agreement with the gold standard, with a weighted root mean squared normalized error below 2.8%. In vivo, a median standard deviation of 31 ms and an interquartile range of [27, 39] ms was achieved across all measurements, including the intra‐ and inter‐repeatability study data. A within‐subject standard deviation for of 21 ± 5 ms had a corresponding repeatability coefficient of 60 ms. The measured values agree well with MOLLI and SASHA mapping methods, with average differences of 5%. Conclusion: Accurate and precise 3D liver measurements can lead the way to the wider adoption of a clinically feasible measurement as a marker of hepatic fibro‐inflammation.


  • Open Access

    Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis

    by Dimitrios A. Koutoukidis, Sandi Yen, Paula Gomez Castro, Mariya Misheva, Susan A. Jebb, Paul Aveyard, Jeremy W. Tomlinson, Ferenc E. Mozes, Jeremy F. Cobbold, Jethro S. Johnson, et al.

    Weight loss improves metabolic dysfunction-associated steatohepatitis (MASH). We investigated whether there were associated changes in intestinal permeability, short-chain fatty acids (SCFAs), and gut microbiota, which are implicated in the pathophysiology of MASH. Sixteen adults with MASH, moderate fibrosis, and obesity received a low-energy total diet replacement program for 12 weeks and stepped food re-introduction over the following 12 weeks (ISRCTN12900952). Intestinal permeability, fecal SCFAs, and fecal microbiota were assessed at 0, 12, and 24 weeks. Data were analyzed using mixed-effects linear regression and sparse partial least-squares regression. Fourteen participants completed the trial, lost 15% (95% CI: 11.2-18.6%) of their weight, and 93% had clinically relevant reductions in liver disease severity markers. Serum zonulin concentrations were reduced at both 12 and 24 weeks (152.0 ng/ml, 95% CI: 88.0-217.4, p < 0.001). Each percentage point of weight loss was associated with a 13.2 ng/mL (95% CI: 3.8-22.5, p < 0.001) reduction in zonulin. For every 10 ng/mL reduction in zonulin, there was a 6.8% (95% CI: 3.5%-10.2, p < 0.001) reduction in liver fat. There were reductions in SCFA and alpha diversity evenness as well as increases in beta diversity of the gut microbiota at 12 weeks, but the changes did not persist at 24 weeks. In conclusion, substantial dietary energy restriction is associated with significant improvement in MASH markers alongside reduction in intestinal permeability. Changes in gut microbiota and SCFA were not maintained with sustained reductions in weight and liver fat, suggesting that microbiome modulation may not explain the relationship between weight loss and improvements in MASH.


  • Open Access

    Ion carrier modulated MRI contrast

    by Anna M. Duncan, Connor M. Ellis, Hannah Levingston, Aidan Kerckhoffs, Ferenc E. Mózes, Matthew J. Langton, Jason J. Davis

    An ion-responsive MRI contrast agent based on a POPC liposomal scaffold is generated that displays a large amplitude relaxivity switch. Entrapment of MR active Gd-DOTA within cholesterol-doped, i.e., membrane rigidified, liposomes dampens the MR response through diminished water exchange across the lipid bilayer. Relaxivity is re-established by integration of ion carriers in the liposome membrane to mediate solvated ion flux.


  • Open Access

    Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH —An individual participant data meta‐analysis

    by Ferenc E Mózes, Jenny A Lee, Yasaman Vali, Emmanuel A Selvaraj, Arjun N A Jayaswal, Jérôme Boursier, Victor de Lédinghen, Monica Lupșor-Platon, Yusuf Yilmaz, Wah-Kheong Chan, et al.

    Background & Aims: There is a need to reduce the screen failure rate (SFR) in metabolic dysfunction‐associated steatohepatitis (MASH) clinical trials (MASH+F2‐3; MASH+F4) and identify people with high‐risk MASH (MASH+F2‐4) in clinical practice. We aimed to evaluate non‐invasive tests (NITs) screening approaches for these target conditions. Methods: This was an individual participant data meta‐analysis for the performance of NITs against liver biopsy for MASH+F2‐4, MASH+F2‐3 and MASH+F4. Index tests were the FibroScan‐AST (FAST) score, liver stiffness measured using vibration‐controlled transient elastography (LSM‐VCTE), the fibrosis‐4 score (FIB‐4) and the NAFLD fibrosis score (NFS). Area under the receiver operating characteristics curve (AUROC) and thresholds including those that achieved 34% SFR were reported. Results: We included 2281 unique cases. The prevalence of MASH+F2‐4, MASH+F2‐3 and MASH+F4 was 31%, 24% and 7%, respectively. Area under the receiver operating characteristics curves for MASH+F2‐4 were .78, .75, .68 and .57 for FAST, LSM‐VCTE, FIB‐4 and NFS. Area under the receiver operating characteristics curves for MASH+F2‐3 were .73, .67, .60, .58 for FAST, LSM‐VCTE, FIB‐4 and NFS. Area under the receiver operating characteristics curves for MASH+F4 were .79, .84, .81, .76 for FAST, LSM‐VCTE, FIB‐4 and NFS. The sequential combination of FIB‐4 and LSM‐VCTE for the detection of MASH+F2‐3 with threshold of .7 and 3.48, and 5.9 and 20 kPa achieved SFR of 67% and sensitivity of 60%, detecting 15 true positive cases from a theoretical group of 100 participants at the prevalence of 24%. Conclusions: Sequential combinations of NITs do not compromise diagnostic performance and may reduce resource utilisation through the need of fewer LSM‐VCTE examinations.